Hong Kong Pharmaceuticals Stock News

CStone Pharmaceuticals (SEHK:2616) has drawn fresh attention after signing an exclusive commercialization agreement with Arrotex Pharmaceuticals for its cancer drug sugemalimab in Australia and New Zealand. The deal includes a profit share structure. See our latest analysis for CStone Pharmaceuticals. CStone Pharmaceuticals' latest commercialization deal and recent insider share purchases come after a sharp 42.03% decline in the 90 day share price return. However, a 22.90% 7 day share price...

Crypto linked stocks are back in focus as Kevin Warsh’s comments on easing inflation, rising crypto asset prices, and mixed ETF flows pull attention toward companies most exposed to Bitcoin, Ethereum and other tokens. While spot Bitcoin ETFs are seeing outflows of US$296 million and Ethereum products are attracting fresh inflows, Solana and other major cryptos are drawing interest from investors looking for potential long term utility. This article explains how that mix of signals could...

China Oilfield Services (SEHK:2883) has announced a broad reshuffle of its senior leadership, including the resignation of its Chairman, Chief Executive Officer and certain executive directors, along with the appointment of new top executives. See our latest analysis for China Oilfield Services. At a share price of HK$6.44, China Oilfield Services has seen short term share price pressure with a 30 day share price return that declined 20.00% and a 90 day share price return that fell 30.53%...

Impro Precision Industries (SEHK:1286) has reshaped its board, with Zhu Liwei stepping down as director to focus on expanding the Aerotek Business Unit and veteran plant manager Zhang Yong Feng joining the board and sustainability committee. See our latest analysis for Impro Precision Industries. The recent board reshuffle comes after a strong run in Impro Precision Industries' shares, with a 1-day share price return of 10.64% and a 70.55% year to date share price return, alongside a very...

BYD (SEHK:1211) is back in focus after reporting its second consecutive month of global sales growth in June, with very strong overseas demand helping to offset weaker volumes in China. See our latest analysis for BYD. BYD's latest sales update comes as the stock trades at HK$84.1, with a 1-day share price return of 7.41% and a 7-day share price return of 15.76%. However, share price returns over 30 days and year to date, along with a 12 month total shareholder return that is down 30.45%,...

SJM Holdings (SEHK:880) drew investor attention after Chief Financial Officer Ip Shih Ming, Christopher resigned on June 29, and the company appointed experienced finance executive Tan Sean Czoon as his successor. See our latest analysis for SJM Holdings. The CFO transition comes after a period where SJM Holdings' share price has been under pressure, with a 30 day share price return down 19.58% and the year to date share price return down 37.19%, alongside a 1 year total shareholder return...

Want Want China Holdings (SEHK:151) is back in focus after releasing full year results to March 31, 2026, together with a proposed lower final ordinary dividend, putting profitability and cash returns to shareholders under the spotlight. See our latest analysis for Want Want China Holdings. The latest earnings and dividend update appears to have sharpened attention on Want Want China Holdings' profitability, with the stock closing at HK$3.24 and a 1-day share price return of 2.53% following a...

Hansoh Pharmaceutical Group (SEHK:3692) has received approval from China's National Medical Products Administration to start clinical trials of its HS-20136-2 injection for type 2 diabetes and obesity, drawing fresh attention to the stock. See our latest analysis for Hansoh Pharmaceutical Group. The clinical trial approval arrives after a sharp swing in sentiment, with Hansoh Pharmaceutical Group’s share price up 17.59% over the past week and 13.09% over 30 days, even though the 90 day share...

Insiders who bought CN¥21.4m worth of Shanghai Junshi Biosciences Co., Ltd. ( HKG:1877 ) stock in the last year...

Xtep International Holdings (SEHK:1368) has cut the conversion prices on its 2021, 2024, and 2026 convertible bonds after declaring a final dividend for the 2025 financial year, slightly changing future potential share issuance. See our latest analysis for Xtep International Holdings. Against this bond conversion adjustment, Xtep International Holdings’ share price of HK$3.84 reflects weak recent momentum, with the 30 day share price return down 14.48% and the year to date share price return...

Cirrus Aircraft (SEHK:2507) just packed several corporate events into a single day by opening a multi million dollar Talent Center in Duluth, approving KPMG as auditor, and declaring a final dividend. See our latest analysis for Cirrus Aircraft. These updates come after a mixed stretch for Cirrus Aircraft’s stock, with a 1-day share price return of 2.77% and 7-day share price return of 10.12%, but a year to date share price return down 41.22% and a 1-year total shareholder return down 12.92%...

Investors who take an interest in AK Medical Holdings Limited ( HKG:1789 ) should definitely note that the VP...

REPT BATTERO Energy (SEHK:666) drew investor attention after using Intersolar Europe 2026 to showcase its Wending 320Ah Sodium Cell and Powtrix 6.9MWh Energy Storage System, both designed for long-duration and utility-scale storage needs. See our latest analysis for REPT BATTERO Energy. Against this backdrop of new energy storage products, REPT BATTERO Energy’s recent share price performance has been mixed. The 1-day share price return of 3.59% and the 7-day share price return of 3.12%...

Genertec Universal Medical Group (SEHK:2666) drew investor focus after its annual general meeting on 24 June 2026, where shareholders approved a final dividend of HK$0.36 per share and amendments to the company’s articles of association. See our latest analysis for Genertec Universal Medical Group. At a share price of HK$4.62, Genertec Universal Medical Group has seen short term share price returns pick up, with gains of 3.36% over one day and 5.24% over seven days. However, the 30 day share...

China Shenhua Energy (SEHK:1088) has brought the No. 5 ultra-supercritical coal-fired units at its Dingzhou and Cangdong Phase III projects into commercial operation after completing 168-hour trials under Hebei’s 14th Five-Year Plan. See our latest analysis for China Shenhua Energy. Despite the new ultra supercritical units entering commercial operation, China Shenhua Energy’s share price has been under pressure in the short term, with a 1 month share price return of down 14.13% and a 3 month...

Luk Fook Holdings (International) (SEHK:590) drew attention after releasing full year earnings to March 31, 2026, alongside a higher recommended final dividend and board changes involving independent non executive directors and key board committees. See our latest analysis for Luk Fook Holdings (International). The latest full year earnings and dividend news comes after a mixed price pattern for Luk Fook Holdings (International), with the share price up 9.30% over 30 days but down 3.14% over...

Nona Biosciences, part of HBM Holdings (SEHK:2142), has entered a collaboration with Lonza to co-develop single domain antibody blood brain barrier crossing technology for central nervous system diseases, drawing fresh attention to HBM Holdings stock. See our latest analysis for HBM Holdings. The Lonza partnership has arrived at a time when HBM Holdings’ share price has gained 5.47% in the last day and 13.12% over the past week, yet remains down 21.35% over 90 days. Meanwhile, the 1 year...

Great Wall Motor (SEHK:2333) has laid out an international expansion plan, targeting a 3% to 5% share of the European car market by 2030. The plan is anchored by the Ora 5 urban SUV launch. See our latest analysis for Great Wall Motor. Great Wall Motor's HK$8.85 share price has seen a sharp short term pullback, with the 30 day share price return down 15.47% and the year to date share price return down 41.47%. The 3 year total shareholder return of 7.40% contrasts with a 26.33% decline over...

Sun Hung Kai Properties (SEHK:16) drew attention after its technology arm SUNeVision secured a major new customer for the MEGA IDC facility, with Phase One occupancy expected to increase from 30% to about 70% and later phases to be accelerated. See our latest analysis for Sun Hung Kai Properties. Recent trading reflects that this SUNeVision contract has arrived during a mixed period for Sun Hung Kai Properties, with the share price at HK$115.3, a 1-day share price return of 1.86%, a...

Event overview: Qatar Airways sale and leaseback deal BOC Aviation (SEHK:2588) drew fresh attention after announcing agreements to purchase three Airbus A350-1000 aircraft from Qatar Airways and lease them back under long term arrangements. The aircraft were delivered in late 2025, and the company classifies the deal as a Qualified Aircraft Leasing Activity and a discloseable transaction under Hong Kong listing rules, which underscores its relevance within sector norms. See our latest...

Sinotruk (Hong Kong) (SEHK:3808) shareholders approved a final dividend at the 29 June 2026 AGM, offering either HK$0.88 or CN¥0.78 per share for the year ended 31 December 2025. See our latest analysis for Sinotruk (Hong Kong). The dividend decision comes as Sinotruk (Hong Kong)'s share price has risen strongly over the year, with a year to date share price return of 49.32%, while the 1 year total shareholder return of 83.71% and 5 year total shareholder return of 276.36% indicate momentum...

JD Health International Inc. ( HKG:6618 ) saw a double-digit share price rise of over 10% in the past couple of months...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...